Advances in the development of influenza virus vaccines

作者: Florian Krammer , Peter Palese

DOI: 10.1038/NRD4529

关键词:

摘要: … broad or universal influenza virus coverage are currently in … influenza virus vaccines could abolish the need for annual reformulation and re-administration of seasonal influenza virus …

参考文章(224)
Giuseppe Del Giudice, Rino Rappuoli, Inactivated and Adjuvanted Influenza Vaccines Current Topics in Microbiology and Immunology. ,vol. 386, pp. 151- 180 ,(2014) , 10.1007/82_2014_406
Hong Jin, Kanta Subbarao, Live Attenuated Influenza Vaccine Current Topics in Microbiology and Immunology. ,vol. 386, pp. 181- 204 ,(2014) , 10.1007/82_2014_410
Vaccine for prevention of influenza in children. The New England Journal of Medicine. ,vol. 370, pp. 1167- 1167 ,(2014) , 10.1056/NEJMC1400874
Philip R. Dormitzer, Rapid Production of Synthetic Influenza Vaccines Current Topics in Microbiology and Immunology. ,vol. 386, pp. 237- 273 ,(2014) , 10.1007/82_2014_399
A. M.-M. Payne, The influenza programme of WHO. Bulletin of The World Health Organization. ,vol. 8, pp. 755- 774 ,(1953)
Caitlin E. Mullarkey, Amy Boyd, Arjan van Laarhoven, Eric A. Lefevre, B. Veronica Carr, Massimiliano Baratelli, Eleonora Molesti, Nigel J. Temperton, Colin Butter, Bryan Charleston, Teresa Lambe, Sarah C. Gilbert, Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+M1 coadministration with inactivated influenza vaccine European Journal of Immunology. ,vol. 43, pp. 1940- 1952 ,(2013) , 10.1002/EJI.201242922
Sabine Neirynck, Tom Deroo, Xavier Saelens, Peter Vanlandschoot, Willy Min Jou, Walter Fiers, A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Medicine. ,vol. 5, pp. 1157- 1163 ,(1999) , 10.1038/13484
Ji-Young Min, Elaine W. Lamirande, Hong Jin, Kathy L. Coelingh, George W. Kemble, Kanta Subbarao, Kawsar R. Talaat, Ruth A. Karron, Philana H. Liang, Bridget A. McMahon, Catherine J. Luke, Bhagvanji Thumar, Grace L. Chen, An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults Influenza and Other Respiratory Viruses. ,vol. 7, pp. 66- 73 ,(2013) , 10.1111/J.1750-2659.2012.00350.X
Karim El Bakkouri, Francis Descamps, Marina De Filette, Anouk Smet, Els Festjens, Ashley Birkett, Nico Van Rooijen, Sjef Verbeek, Walter Fiers, Xavier Saelens, Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection The Journal of Immunology. ,vol. 186, pp. 1022- 1031 ,(2011) , 10.4049/JIMMUNOL.0902147
E Kissling, M Valenciano, A Larrauri, B Oroszi, J M Cohen, B Nunes, D Pitigoi, C Rizzo, J Rebolledo, I Paradowska-Stankiewicz, S Jiménez-Jorge, J K Horváth, I Daviaud, R Guiomar, G Necula, A Bella, J O’Donnell, M Głuchowska, B C Ciancio, A Nicoll, A Moren, Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study Eurosurveillance. ,vol. 18, pp. 20390- ,(2013) , 10.2807/ESE.18.05.20390-EN